In addition, it is recommended that the duration of future clinical trials of GLP-1RAs for AD extend to 2 to 3 years to evaluate long-term outcomes, including changes in cognition, activities of daily living, instrumental activities of daily living, and biomarkers for tau and A
Ask who prescribes it, where it is compounded, how the dose is supplied, and whether labs and an MD review come first
Reduced responsivity to high doses of sucrose is also reported from gustatory nerve recordings in GLP-1R KO mice [122]
Castro, B
It means that BPC-157 remains outside standard FDA-approved treatment pathways and should be used thoughtfully under physician guidance
Paradoxical worsening, where skin looks worse despite using a product intended to improve it, may indicate concentration-related MMP imbalance